STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
BGNE BEIGENE LIMITED StockScouter® Report
6
StockScouter® Score
BEIGENE LIMITED, a mid cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- The multi-period measure of relative price change and consistency is well above average. Positive
Concerns
- One or more analysts has significantly decreased quarterly earnings estimates for BGNE. Negative
- Two or more executives, board directors or major shareholders – including one high-level executive -- sold a large number of shares recently. Very negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
B
F
D
A